fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2024

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

De La Fouchardière C

Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.

2024

Seminars in hematology

Pagliuca S

Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence.

2024

Clinical and experimental medicine

Witz A

Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?

2024

Histopathology

Fattori A

Coxal giant cell-rich tumour harbouring an NUTM1 gene fusion: a new molecular subtype of giant cell tumour of bone?

2024

Frontiers in medicine

Ouvrard E

Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?

2024

The Journal of dermatology

Longo R

A metastatic, cutaneous mucinous carcinoma revealed by the 16α- F-fluoroestradiol ( F-FES) PET/CT scan and successfully treated by hormonotherapy: Description of a case report.

2024

International journal of molecular sciences

Hotton J

Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features.

2024

The journal of vascular access

Amroun K

Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.

2024

Nutrition (Burbank, Los Angeles County, Calif.)

Roux-Levy C

Association between polyunsaturated fatty acids in adipose tissue and mortality of colorectal cancer patients.

2024

Frontiers in oncology

Ilie SM

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.